- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Alliance Imaging adds to acquisitions
Mobile imaging provider Alliance Imaging announced last week thatit intends to add to its presence in the eastern U.S. with theacquisition of a mobile MRI firm based in the region. Allianceof Orange, CA, declined to name the firm pending the close ofthe
Mobile imaging provider Alliance Imaging announced last week that
it intends to add to its presence in the eastern U.S. with the
acquisition of a mobile MRI firm based in the region. Alliance
of Orange, CA, declined to name the firm pending the close of
the transaction. Alliance did say, however, that the company operates
a half-dozen MRI routes and will increase Alliance's revenues
by almost 10% a year. When completed, the deal will be Alliance's
third acquisition in a year (SCAN 3/27/96 and 9/27/95).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
